Pfizer Inc. March 31 announced that it has released information about payments or other things of value given to health care professionals who consulted with the company about the development and marketing of new medicines.
The company said the information also includes details on payments made to physicians who helped to educate other health care professionals about the safe and appropriate use of its products. In addition, the information will include payments made for conducting phase I through IV clinical trials.
The report, which was posted on the company’s website, includes data collected from July through December 2009 about ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.